Here’s what you should know:
1. Mr. Ingram will serve on the company’s board as well.
2. He has more than two decades of executive leadership experience.
3. Edward Kaye, MD, is stepping down from his leadership positions, but will serve the company in an advisor’s role.
4. Mr. Ingram was president of Allergan until it was acquired by Actavis in 2015.
More articles on improving health:
Successful total joint replacement bundles in ASCs: 2 factors to prioritize
30 things for ASC leaders to know for June
Where ASCs fit in a consolidating marketplace — Is independence an option?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
